(Q36492598)

14 August 2017

1 reference

title

Particulate delivery systems for vaccines: what can we expect? (English)

1 reference

14 August 2017

Vincent W Bramwell

1

1 reference

PubMed ID

16734973

14 August 2017

Yvonne Perrie

series ordinal

2

1 reference

PubMed ID

16734973

14 August 2017

language of work or name

1 reference

1 June 2006

1 reference

Journal of Pharmacy and Pharmacology

14 August 2017

1 reference

14 August 2017

58

1 reference

14 August 2017

6

1 reference

14 August 2017

717-728

1 reference

Bacterial CpG-DNA and lipopolysaccharides activate Toll-like receptors at distinct cellular compartments

14 August 2017

1 reference

https://api.crossref.org/works/10.1211%2FJPP.58.6.0002

Current status of DNA vaccines and their route of administration

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.58.6.0002

Intranasal vaccination against plague, tetanus and diphtheria

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.58.6.0002

Cationic liposomes induce macrophage apoptosis through mitochondrial pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.58.6.0002

Liposomal meningococcal B vaccination: role of dendritic cell targeting in the development of a protective immune response.

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.58.6.0002

Protective role of phospholipid oxidation products in endotoxin-induced tissue damage

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.58.6.0002

Particulate delivery systems for vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.58.6.0002

The rational design of vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.58.6.0002

Caspase-dependent immunogenicity of doxorubicin-induced tumor cell death

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.58.6.0002

Use of the nirB promoter to direct the stable expression of heterologous antigens in Salmonella oral vaccine strains: development of a single-dose oral tetanus vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.58.6.0002

PUBLIC HEALTH: High Hopes and Dilemmas for a Cervical Cancer Vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.58.6.0002

Resorbable lamellar particles of polylactide as adjuvants for influenza virus vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.58.6.0002

Virosomes for antigen and DNA delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.58.6.0002

Characterization of cationic liposomes based on dimethyldioctadecylammonium and synthetic cord factor from M. tuberculosis (trehalose 6,6'-dibehenate)-a novel adjuvant inducing both strong CMI and antibody responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.58.6.0002

Adaptor usage and Toll-like receptor signaling specificity

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.58.6.0002

Protection against bubonic and pneumonic plague with a single dose microencapsulated sub-unit vaccine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.58.6.0002

Microsphere translocation and immunopotentiation in systemic tissues following intranasal administration

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.58.6.0002

Immunological aspects of polymer microsphere vaccine delivery systems

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.58.6.0002

Effect of cationic cholesterol derivatives on gene transfer and protein kinase C activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.58.6.0002

Liposomes and virosomes as delivery systems for antigens, nucleic acids and drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.58.6.0002

Anti-inflammatory activity of cationic lipids

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.58.6.0002

Polymer-coated adenovirus permits efficient retargeting and evades neutralising antibodies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.58.6.0002

Interaction of dendritic cells with antigen-containing liposomes: effect of bilayer composition

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.58.6.0002

Need for new vaccine formulations and potential of particulate antigen and DNA delivery systems

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.58.6.0002

Vaccine entrapment in liposomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.58.6.0002

Protection against plague following immunisation with microencapsulated V antigen is reduced by co-encapsulation with IFN-gamma or IL-4, but not IL-6.

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.58.6.0002

The isoform-specific regulation of apoptosis by protein kinase C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.58.6.0002

Nasal immunization with diphtheria toxoid conjugated-CD52 core peptide induced specific antibody production in genital tract of female mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.58.6.0002

Lysophosphatidylcholine increases endothelial permeability: role of PKCalpha and RhoA cross talk

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.58.6.0002

Biodegradable poly(lactic-co-glycolic acid) microparticles for injectable delivery of vaccine antigens

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.58.6.0002

The human macrophage mannose receptor directs Mycobacterium tuberculosis lipoarabinomannan-mediated phagosome biogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.58.6.0002

Influence of particle size, antigen load, dose and additional adjuvant on the immune response from antigen loaded PLA microparticles

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.58.6.0002

Bacterial modulation of mucosal innate immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.58.6.0002

Influence of phospholipid composition on the adjuvanticity and protective efficacy of liposome-encapsulated Leishmania donovani antigens

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.58.6.0002

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.58.6.0002

Iscom, a novel structure for antigenic presentation of membrane proteins from enveloped viruses.

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.58.6.0002

NF-kappaB activation by protein kinase C isoforms and B-cell function

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.58.6.0002

Adjuvant synergy: the effects of nasal coadministration of adjuvants.

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.58.6.0002

Development of a CTL vaccine for Her-2/neu using peptide-microspheres and adjuvants.

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.58.6.0002

Selected Toll-like receptor agonist combinations synergistically trigger a T helper type 1-polarizing program in dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.58.6.0002

Future directions of liposome- and immunoliposome-based cancer therapeutics

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.58.6.0002

ISCOMATRIX adjuvant for antigen delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.58.6.0002

Liposome-mediated DNA vaccination: the effect of vesicle composition

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.58.6.0002

Liposome-mediated DNA immunisation via the subcutaneous route

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.58.6.0002

In vivo uptake of an experimental microencapsulated diphtheria vaccine following sub-cutaneous immunisation

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.58.6.0002

Characterization of the structural proteins of hepatitis C virus expressed by an adenovirus recombinant

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.58.6.0002

Cationic liposomes containing mycobacterial lipids: a new powerful Th1 adjuvant system

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.58.6.0002

Induction of effective and antigen-specific antitumour immunity by a liposomal ErbB2/HER2 peptide-based vaccination construct

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.58.6.0002

Transcriptionally targeted adenovirus vectors

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.58.6.0002

Adenoviral vectors for mucosal vaccination against infectious diseases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.58.6.0002

Anionic microparticles are a potent delivery system for recombinant antigens from Neisseria meningitidis serotype B.

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.58.6.0002

Effect of vitamin E TPGS on immune response to nasally delivered diphtheria toxoid loaded poly(caprolactone) microparticles

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.58.6.0002

Acid-degradable particles for protein-based vaccines: enhanced survival rate for tumor-challenged mice using ovalbumin model

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.58.6.0002

Modification of liposomal concentration in liposome/adenoviral complexes allows significant protection of adenoviral vectors from neutralising antibody, in vitro.

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.58.6.0002

Liposome-encapsulated CpG oligodeoxynucleotides as a potent adjuvant for inducing type 1 innate immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.58.6.0002

Chemically synthesized pathogen-associated molecular patterns increase the expression of peptidoglycan recognition proteins via toll-like receptors, NOD1 and NOD2 in human oral epithelial cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.58.6.0002

Modification of lipid A biosynthesis in Neisseria meningitidis lpxL mutants: influence on lipopolysaccharide structure, toxicity, and adjuvant activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.58.6.0002

Three double-blind, randomized trials evaluating the safety and tolerance of different formulations of the saponin adjuvant QS-21.

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.58.6.0002

The immunophysiological impact of bacterial CpG DNA on the gut.

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.58.6.0002

Activation of dendritic cells by microparticles containing Bacillus anthracis protective antigen

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.58.6.0002

Immunological responses after immunisation of mice with microparticles containing antigen and single stranded RNA (polyuridylic acid).

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.58.6.0002

Apoptosis paves the detour path for CD8 T cell activation against intracellular bacteria

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.58.6.0002

Expression of vaccinia recombinant HPV 16 L1 and L2 ORF proteins in epithelial cells is sufficient for assembly of HPV virion-like particles.

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.58.6.0002

Antigen localisation regulates immune responses in a dose- and time-dependent fashion: a geographical view of immune reactivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.58.6.0002

Synergistic enhancement of Toll-like receptor responses by NOD1 activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.58.6.0002

Liposomes as immunological adjuvants

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.58.6.0002

Analysis of the role of vaccine adjuvants in modulating dendritic cell activation and antigen presentation in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.58.6.0002

21 January 2018

Identifiers

DOI

10.1211/JPP.58.6.0002

1 reference

14 August 2017

1 reference

PubMed ID

16734973